Development of 2,9‐Disubstituted Acridines as Topoisomerase IIα Inhibitors with Strong Anticancer Activity: Synthesis, Biological Evaluation, and In Silico Study
ChemMedChem · 2025
DOI: 10.1002/cmdc.202500267 ↗Kurz gefasst
Fachartikel in der Zeitschrift ChemMedChem, 2025. Verfasst von Ladislav Janovec und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Organic Chemistry, Institute of Chemistry, Faculty of Science, P. J. Šafárik University in Košice, Moyzesova 11, 040 01, Košice, Slovak…. Hauptthemen laut MEDLINE: Acridines, Antineoplastic Agents, Topoisomerase II Inhibitors, DNA Topoisomerases, Type II. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: VEGA, ERDF, Operational Programme Integrated Infrastructure, ERDF, Operational Programme Research & Innovation.
Abstract (Originalsprache)
A series of 2,9‐disubstituted acridines ( 16a – 16h ) is synthetized and assessed for their biological activities. The acridines feature various 9‐anilino or 9‐phenylalkyl substituents and are prepared via a linear sequence of six steps using commercially available starting materials. The relationship between the physicochemical properties of the 2,9‐disubstituted acridines and their biological activity is studied, and the DNA binding capacities of the synthetized acridines are determined using spectroscopic ( K b 0.5–10.4 × 10 4 M −1 ) and thermal denaturation (Δ T m 4.2–9.8 °C) methods. The inhibitory potential of acridines 16a – 16h toward human topoisomerase I/IIα is evaluated, and 9‐phenylbutyl acridine 16h is found to inhibit human topoisomerase IIα at concentrations as low as 5 μ m . Acridines 16a – 16h are also subjected to in vitro screening against selected cancer cell lines; the most potent anticancer activity is observed against melanoma A2058 cell lines at IC 50 values ranging from 3 to 6 μ m .
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Organic Chemistry, Institute of Chemistry, Faculty of Science, P. J. Šafárik University in Košice, Moyzesova 11, 040 01, Košice, Slovak Republic.
- Department of Biochemistry, Institute of Chemistry, Faculty of Science, P. J. Šafárik University in Košice, Moyzesova 11, 040 01, Košice, Slovak Republic.
- Department of Pharmacology, Faculty of Medicine, P. J. Šafarik University in Kosice, Tr. SNP 1, 040 11, Košice, Slovak Republic.
- Institute of Geotechnics, Slovak Academy of Sciences, Watsonova 45, 040 01, Kosice, Slovak Republic.
ORCID-Profile: Ladislav Janovec
Förderung
- VEGA
- ERDF, Operational Programme Integrated Infrastructure
- ERDF, Operational Programme Research & Innovation
- Vedecká Grantová Agentúra MŠVVaŠ SR a SAV
Zitieren
APA
Janovec, L., Gucký, A., Krochtová, K., Michalková, R., Kušnírová, K., Miškufová, V., Jáger, D., Mojžiš, J., & Kožurková, M. (2025). Development of 2,9‐Disubstituted Acridines as Topoisomerase IIα Inhibitors with Strong Anticancer Activity: Synthesis, Biological Evaluation, and In Silico Study. ChemMedChem. https://doi.org/10.1002/cmdc.202500267
Vancouver
Janovec L, Gucký A, Krochtová K, Michalková R, Kušnírová K, Miškufová V, et al. Development of 2,9‐Disubstituted Acridines as Topoisomerase IIα Inhibitors with Strong Anticancer Activity: Synthesis, Biological Evaluation, and In Silico Study. ChemMedChem. 2025. doi:10.1002/cmdc.202500267
BibTeX
@article{Janovec2025,
author = {Janovec, Ladislav and Gucký, Adrian and Krochtová, Kristína and Michalková, Radka and Kušnírová, Katarína and Miškufová, Viktória and Jáger, Dávid and Mojžiš, Ján and Kožurková, Mária},
title = {Development of 2,9‐Disubstituted Acridines as Topoisomerase IIα Inhibitors with Strong Anticancer Activity: Synthesis, Biological Evaluation, and In Silico Study},
journal = {ChemMedChem},
year = {2025},
doi = {10.1002/cmdc.202500267}
}
EUVIMED